BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21528083)

  • 21. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
    Kotti A; Holmqvist A; Albertsson M; Sun XF
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of CEA and p53 overexpression in the poor prognosis of colorectal cancer.
    Nasif WA; Lotfy M; El-Sayed IH; El-Kenawy Ael-M; El-Shahat M; El-Hak NG
    Med Oncol; 2006; 23(2):237-44. PubMed ID: 16720924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
    Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
    Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA; Kim SH; Hong HK; Yun SH; Kim HC; Chun HK; Cho YB; Lee WY
    Oncology; 2014; 86(5-6):318-28. PubMed ID: 24924873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
    Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
    World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mismatch repair protein MSH2, cytokeratin 18 and cytokeratin 20 expression: clinicopathological correlation and prognostic value in colorectal cancer patients.
    González JJ; Bernardo CG; Sanz L; Fresno MF; Barbón E; Noval JG; Martínez E
    Hepatogastroenterology; 2007 Dec; 54(80):2266-71. PubMed ID: 18265645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matricellular protein SPARCL1 regulates tumor microenvironment-dependent endothelial cell heterogeneity in colorectal carcinoma.
    Naschberger E; Liebl A; Schellerer VS; Schütz M; Britzen-Laurent N; Kölbel P; Schaal U; Haep L; Regensburger D; Wittmann T; Klein-Hitpass L; Rau TT; Dietel B; Méniel VS; Clarke AR; Merkel S; Croner RS; Hohenberger W; Stürzl M
    J Clin Invest; 2016 Nov; 126(11):4187-4204. PubMed ID: 27721236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SHP2 associates with nuclear localization of STAT3: significance in progression and prognosis of colorectal cancer.
    Huang Y; Wang J; Cao F; Jiang H; Li A; Li J; Qiu L; Shen H; Chang W; Zhou C; Pan Y; Lu Y
    Sci Rep; 2017 Dec; 7(1):17597. PubMed ID: 29242509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
    Zakout YM; Lanza G
    J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
    Zheng L; Xie G; Duan G; Yan X; Li Q
    PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High expression of fibronectin is associated with poor prognosis, cell proliferation and malignancy via the NF-κB/p53-apoptosis signaling pathway in colorectal cancer.
    Yi W; Xiao E; Ding R; Luo P; Yang Y
    Oncol Rep; 2016 Dec; 36(6):3145-3153. PubMed ID: 27748871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
    Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
    Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Species-, organ- and cell-type-dependent expression of SPARCL1 in human and mouse tissues.
    Klingler A; Regensburger D; Tenkerian C; Britzen-Laurent N; Hartmann A; Stürzl M; Naschberger E
    PLoS One; 2020; 15(5):e0233422. PubMed ID: 32437418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53, Cyclin-D1, β-catenin, APC and c-myc in Tumor Tissue from Colorectal and Gastric Cancer Patients with Suspected Lynch Syndrome by the Bethesda Criteria.
    Marcolino TF; Pimenta CAM; Artigiani Neto R; Castelo P; Silva MS; Forones NM; Oshima CTF
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):343-348. PubMed ID: 32102509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mismatch repair protein MSH2 expression and prognosis of colorectal cancer patients.
    Bernardo CG; González JJ; Sanz L; Barbón E; Noval JG; Fresno MF; Aza J
    Int J Biol Markers; 2004; 19(3):190-5. PubMed ID: 15503820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
    Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
    World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tenascin-C as a prognostic determinant of colorectal cancer through induction of epithelial-to-mesenchymal transition and proliferation.
    Yang Z; Zhang C; Qi W; Cui C; Cui Y; Xuan Y
    Exp Mol Pathol; 2018 Oct; 105(2):216-222. PubMed ID: 30170017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
    Gao M; Zhang X; Li D; He P; Tian W; Zeng B
    Oncotarget; 2016 Dec; 7(51):85502-85514. PubMed ID: 27907907
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of MutL homologue MLH1 and MutS homologue MSH2 expression in Turkish patients with sporadic colorectal cancer.
    Erdamar S; Ucaryilmaz E; Demir G; Karahasanoglu T; Dogusoy G; Dirican A; Goksel S
    World J Gastroenterol; 2007 Sep; 13(33):4437-44. PubMed ID: 17724798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer.
    Kim YJ; Kim MA; Im SA; Kim TM; Kim DW; Yang HK; Heo DS; Lee KU; Choe KJ; Kim NK; Kim TY; Kim WH; Bang YJ
    Cancer Invest; 2008 Mar; 26(2):152-8. PubMed ID: 18259945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.